Exciting Investor news at BIO CEO conference.
February 6-9, 2023
Life Science & Biotech investor meetings are hot in freezing New York, as Brinter®, California-based Biotech/MedTech company, is preparing to present its upcoming Series A round for investors.
Tuesday, February 7, 2:45pm (ET), at Winter Garden Room. BIO CEO and Investor Conference, Marriott Marquis, NYC
If you are interested in learning more about Brinter’s Series-A round and our industry-changing Cartilaginous Bio-Implants and Personalized Drug Printing applications enabled by our patented 3D (bio)printing tech, please don’t hesitate to contact us HERE, and we’ll schedule a meeting with our Brinter Inc CEO Tom Alapaattikoski, at the conference or virtually.
Exciting times ahead, don’t miss it!
WHAT IS BIO CEO & Investor Conference?
Now in its 25th year, the BIO CEO & Investor Conference fuels the biotech industry as a premier event for C-Suite leaders and the investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.